Cargando…
Lessons from a global antimicrobial resistance surveillance network
The World Health Organization developed the Tricycle surveillance programme to obtain a global picture of antimicrobial resistance, especially in countries with limited surveillance capacity. The programme was developed within a One Health perspective. Tricycle provides a framework for applying a st...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
World Health Organization
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10523813/ https://www.ncbi.nlm.nih.gov/pubmed/37772195 http://dx.doi.org/10.2471/BLT.22.289520 |
_version_ | 1785110642942803968 |
---|---|
author | Ruppé, Etienne |
author_facet | Ruppé, Etienne |
author_sort | Ruppé, Etienne |
collection | PubMed |
description | The World Health Organization developed the Tricycle surveillance programme to obtain a global picture of antimicrobial resistance, especially in countries with limited surveillance capacity. The programme was developed within a One Health perspective. Tricycle provides a framework for applying a standardized technical protocol to determining the prevalence of extended-spectrum β-lactamase (ESBL)-producing Escherichia coli in three sectors: the human, animal and environment sectors. Regular use of the protocol would enable information to be obtained on time trends and on inter- and intraregional variations, thereby generating dynamic data on antibacterial resistance for decision-makers. To date, 19 countries have begun implementing the Tricycle protocol, while other countries will start implementation in the coming years. The Network for Enhancing Tricycle ESBL Surveillance Efficiency (NETESE) was established to support countries implementing the Tricycle protocol. Currently, NETESE includes representatives from 15 institutions in eight low- or middle-income countries at different stages of Tricycle protocol implementation, and from four European countries involved in devising the protocol. This paper describes the Tricycle protocol, reports the initial experiences of NETESE participants with its implementation and discusses future challenges and opportunities. |
format | Online Article Text |
id | pubmed-10523813 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | World Health Organization |
record_format | MEDLINE/PubMed |
spelling | pubmed-105238132023-10-01 Lessons from a global antimicrobial resistance surveillance network Ruppé, Etienne Bull World Health Organ Policy & Practice The World Health Organization developed the Tricycle surveillance programme to obtain a global picture of antimicrobial resistance, especially in countries with limited surveillance capacity. The programme was developed within a One Health perspective. Tricycle provides a framework for applying a standardized technical protocol to determining the prevalence of extended-spectrum β-lactamase (ESBL)-producing Escherichia coli in three sectors: the human, animal and environment sectors. Regular use of the protocol would enable information to be obtained on time trends and on inter- and intraregional variations, thereby generating dynamic data on antibacterial resistance for decision-makers. To date, 19 countries have begun implementing the Tricycle protocol, while other countries will start implementation in the coming years. The Network for Enhancing Tricycle ESBL Surveillance Efficiency (NETESE) was established to support countries implementing the Tricycle protocol. Currently, NETESE includes representatives from 15 institutions in eight low- or middle-income countries at different stages of Tricycle protocol implementation, and from four European countries involved in devising the protocol. This paper describes the Tricycle protocol, reports the initial experiences of NETESE participants with its implementation and discusses future challenges and opportunities. World Health Organization 2023-10-01 2023-09-06 /pmc/articles/PMC10523813/ /pubmed/37772195 http://dx.doi.org/10.2471/BLT.22.289520 Text en (c) 2023 The authors; licensee World Health Organization. https://creativecommons.org/licenses/by/3.0/igo/This is an open access article distributed under the terms of the Creative Commons Attribution IGO License (http://creativecommons.org/licenses/by/3.0/igo/legalcode (https://creativecommons.org/licenses/by/3.0/igo/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. In any reproduction of this article there should not be any suggestion that WHO or this article endorse any specific organization or products. The use of the WHO logo is not permitted. This notice should be preserved along with the article's original URL. |
spellingShingle | Policy & Practice Ruppé, Etienne Lessons from a global antimicrobial resistance surveillance network |
title | Lessons from a global antimicrobial resistance surveillance network |
title_full | Lessons from a global antimicrobial resistance surveillance network |
title_fullStr | Lessons from a global antimicrobial resistance surveillance network |
title_full_unstemmed | Lessons from a global antimicrobial resistance surveillance network |
title_short | Lessons from a global antimicrobial resistance surveillance network |
title_sort | lessons from a global antimicrobial resistance surveillance network |
topic | Policy & Practice |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10523813/ https://www.ncbi.nlm.nih.gov/pubmed/37772195 http://dx.doi.org/10.2471/BLT.22.289520 |
work_keys_str_mv | AT ruppeetienne lessonsfromaglobalantimicrobialresistancesurveillancenetwork AT lessonsfromaglobalantimicrobialresistancesurveillancenetwork |